15 Phase 4 Trial Expansion – Now Open in South Africa The PC-PEP Phase 4 trial is expanding internationally, including to South Africa, and is open to any man with a prostate cancer diagnosis—from active surveillance to metastatic disease—with an expected survival of more than two years and medically safe to exercise. This trial features: • Comprehensive quality-of-life assessments at baseline, 6, 12, and 24 months. • Opportunities for co-authorship in pooled data publications. • Zero cost to participants. • Simple enrollment: Takes just 15 seconds in clinic to direct patients to www.PCPEP.org, and our study team will take care of enrollment from there. Join the Movement PC-PEP is more than a program—it's a Community of Empowerment. By participating, men gain tools to take charge of their health, connect with peers, raise awareness of prostate cancer and screening, and contribute to groundbreaking research that is shaping the future of prostate cancer care. “Having experienced the practical and comprehensive PEP program, I am in no doubt that for any man facing prostate cancer, PEP should be an essential and integral part of their health and wellness regime” -Iain Johnston, Patient Affairs Chairman, PCFSA Dr. Gabriela Ilie, PC-PEP Principal Investigator; Dr. Conray Moolman, Robotic Urological Surgeon, Cape Town; Dr. Rob Rutledge, PC-PEP Clinical Lead; and Mr. Cody MacDonald, PC-PEP Project Manager. Dr. Lance Coetzee, Robotic Urological Surgeon, Pretoria and Dr. Gabriela Ilie, PC-PEP Principal Investigator
RkJQdWJsaXNoZXIy NTIyOTQ=